CXCL12: A New Player in Coronary Disease Identified through Human Genetics

Trends in Cardiovascular Medicine

Volumn 20, Issue 6, 2010, Pages 204-209

  Farouk, Samira S ^a   Rader, Daniel J ^a   Reilly, Muredach P ^a   Mehta, Nehal N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST;

ARTERY INJURY; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CHROMOSOME 10Q; CHROMOSOME 11; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; HEART INFARCTION; HUMAN; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

ANIMALS; ARTERIOSCLEROSIS; CHEMOKINE CXCL12; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MYOCARDIAL INFARCTION;

EID: 83055165750     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2011.08.002     Document Type: Review

References (53)

1. Abi-Younes S., Sauty A., Mach F., et al. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000, 2:131-138.
2. Ali S., Lazennec G. Chemokines: Novel targets for breast cancer metastasis. Cancer Metastasis Rev 2007, 3-4:401-420.
3. Apostolakis S., Krambovitis E., Vlata Z., et al. CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: Impact of pre-inflammatory stimuli and renin-angiotensin system modulators. Thromb Res 2007, 3:387-395.
4. Assimes T.L., Knowles J.W., Basu A., et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet 2008, 15:2320-2328.
5. Aukrust P., Halvorsen B., Yndestad A., et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008, 11:1909-1919.
6. Balabanian K., Lagane B., Infantino S., et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005, 42:35760-35766.
7. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 3:1101-1109.
8. Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 2004, 9:858-866.
9. Coll B., Alonso-Villaverde C., Parra S., et al. The stromal derived factor-1 mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-infected patients. AIDS 2005, 16:1877-1883.
10. Damas J.K., Waehre T., Yndestad A., et al. Stromal cell-derived factor-1alpha in unstable angina: Potential antiinflammatory and matrix-stabilizing effects. Circulation 2002, 1:36-42.
11. De La Luz Sierra M., Yang F., Narazaki M., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004, 7:2452-2459.
12. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 3:657-671.
13. Fujiwara K., Matsukawa A., Ohkawara S., et al. Functional distinction between CXC chemokines, interleukin-8 (IL-8), and growth related oncogene (GRO)alpha in neutrophil infiltration. Lab Invest 2002, 1:15-23.
14. Han K.H., Tangirala R.K., Green S.R., Quehenberger O. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes: A regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol 1998, 12:1983-1991.
15. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 16:1685-1695.
16. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 5830:1491-1493.
17. Hinohara K., Nakajima T., Takahashi M., et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 2008, 4:357-359.
18. Kathiresan S., Voight B.F., Purcell S., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 3:334-341.
19. Kiechl S., Laxton R.C., Xiao Q., et al. Coronary artery disease-related genetic variant on chromosome 10q11 is associated with carotid intima-media thickness and atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:2678-2683.
20. Koenen R.R., Weber C. Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin Thromb Hemost 2010, 2:163-169.
21. Ma Q., Jones D., Borghesani P.R., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 16:9448-9453.
22. Massberg S., Konrad I., Schurzinger K., et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006, 5:1221-1233.
23. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 5830:1488-1491.
24. Mehta N.N., Li M., William D., et al. The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels. Eur Heart J 2011, 32:963-971.
25. Mestas J., Hughes C.C. Of mice and not men: Differences between mouse and human immunology. J Immunol 2004, 5:2731-2738.
26. Modi W.S., Scott K., Goedert J.J., et al. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun 2005, 8:691-698.
27. Mohle R., Bautz F., Rafii S., et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998, 12:4523-4530.
28. Murdoch C., Monk P.N., Finn A. Cxc chemokine receptor expression on human endothelial cells. Cytokine 1999, 9:704-712.
29. Nagasawa T., Kikutani H., Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 1994, 6:2305-2309.
30. Pattison J.M., Nelson P.J., Huie P., et al. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 1996, 12:1194-1199.
31. Peden J., Hopewell J., Saleheen D., et al. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011, 4:339-344.
32. Rader D.J., Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008, 7181:904-913.
33. Reilly M.P., Li M., He J., et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: Two genome-wide association studies. Lancet 2011, 9763:383-392.
34. Sainz J., Sata M. Open sesame! CXCR4 blockade recruits neutrophils into the plaque. Circ Res 2008, 2:154-156.
35. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 5:443-453.
36. Schober A., Knarren S., Lietz M., et al. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003, 20:2491-2497.
37. Schunkert H., Konig I., Katherisan S., et al. Nature Genetics 2011, 43:333-338.
38. Schunkert H., Gotz A., Braund P., et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p213 and coronary artery disease. Circulation 2008, 13:1675-1684.
39. Shen G.Q., Rao S., Martinelli N., et al. Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet 2008, 2:144-150.
40. Stellos K., Bigalke B., Langer H., et al. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J 2009, 5:584-593.
41. Teupser D., Pavlides S., Tan M., et al. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 2004, 51:17795-17800.
42. Thelen M., Thelen S. CXCR7, CXCR4 and CXCL12: An eccentric trio?. J Neuroimmunol 2008, 1-2:9-13.
43. Veillard N.R., Steffens S., Pelli G., et al. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 2005, 6:870-878.
44. Wang J.F., Liu Z.Y., Groopman J.E. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 1998, 3:756-764.
45. Wang J.F., Park I.W., Groopman J.E. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: Roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000, 8:2505-2513.
46. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 7145:661-678. Wellcome Trust Case Control Consortium.
47. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 9:1322-1328.
48. Yu L., Cecil J., Peng S.B., et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 2006, 374:174-179.
49. Zernecke A., Bot I., Djalali-Talab Y., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008, 2:209-217.
50. Zernecke A., Schober A., Bot I., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005, 7:784-791.
51. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis. An update. Arterioscler Thromb Vasc Biol 2008, 28:1897-1908.
52. Zernecke A., Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 2010, 2:192-201.
53. Zou Y.R., Kottmann A.H., Kuroda M., et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 6685:595-599.